
Nevirapine (200mg)
Active composition
Nevirapine inhibits the reverse transcriptase enzyme, preventing the conversion of viral RNA to DNA and halting viral replication.
Medical applications
Nevimune Tablet, containing 200mg of Nevirapine, is an essential antiretroviral medication used in the treatment and prevention of HIV-1 infection in adults and pediatric patients. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that functions by inhibiting the HIV-1 reverse transcriptase, thus preventing the viral replication and multiplication. Nevimune Tablet should be administered with other antiretroviral agents as part of a combination therapy, as recommended by the current guidelines for the management of HIV-1 infection. The medication should be taken orally, with or without food, and the dosage may vary based on the patient's weight and the severity of the condition. It is crucial to adhere to a regular dosing schedule to ensure effective viral load suppression and improved clinical outcomes. Nevimune Tablet should be used with caution in patients with liver or kidney dysfunction and in patients coinfected with tuberculosis. Regular monitoring of liver function tests, viral load, and CD4+ cell count is recommended during treatment.
Non-nucleoside analog
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nevimune Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
High Risk
Nevimune Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Nevimune Tablet is safe to use in patients with kidney disease. No dose adjustment of Nevimune Tablet is recommended. However, inform your doctor if you have any underlying kidney disease.
Exercise Caution
Nevimune Tablet may cause side effects which could affect your ability to drive. You may experience fatigue while taking Nevimune Tablet and this may affect your ability to drive.
Consult Doctor
Nevimune Tablet should be used with caution in patients with liver disease. Dose adjustment of Nevimune Tablet may be needed. Please consult your doctor. Use of Nevimune Tablet is not recommended in patients with moderate to severe liver disease. Regular monitoring of liver function tests is advised while you are taking this medicine.
Regular Checkup
0 reviews for Nevimune Tablet

Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Nevirapine inhibits the reverse transcriptase enzyme, preventing the conversion of viral RNA to DNA and halting viral replication.
Medical applications
Nevimune Tablet, containing 200mg of Nevirapine, is an essential antiretroviral medication used in the treatment and prevention of HIV-1 infection in adults and pediatric patients. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that functions by inhibiting the HIV-1 reverse transcriptase, thus preventing the viral replication and multiplication. Nevimune Tablet should be administered with other antiretroviral agents as part of a combination therapy, as recommended by the current guidelines for the management of HIV-1 infection. The medication should be taken orally, with or without food, and the dosage may vary based on the patient's weight and the severity of the condition. It is crucial to adhere to a regular dosing schedule to ensure effective viral load suppression and improved clinical outcomes. Nevimune Tablet should be used with caution in patients with liver or kidney dysfunction and in patients coinfected with tuberculosis. Regular monitoring of liver function tests, viral load, and CD4+ cell count is recommended during treatment.
Non-nucleoside analog
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nevimune Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
High Risk
Nevimune Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Nevimune Tablet is safe to use in patients with kidney disease. No dose adjustment of Nevimune Tablet is recommended. However, inform your doctor if you have any underlying kidney disease.
Exercise Caution
Nevimune Tablet may cause side effects which could affect your ability to drive. You may experience fatigue while taking Nevimune Tablet and this may affect your ability to drive.
Consult Doctor
Nevimune Tablet should be used with caution in patients with liver disease. Dose adjustment of Nevimune Tablet may be needed. Please consult your doctor. Use of Nevimune Tablet is not recommended in patients with moderate to severe liver disease. Regular monitoring of liver function tests is advised while you are taking this medicine.
Regular Checkup
0 reviews for Nevimune Tablet















